Seattle, WA, United States of America

Scot Wayne McKay

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Avm Biotechnology, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scot Wayne McKay. Retrieved from https://idiyas.com/inventor/scot-wayne-mckay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scot Wayne McKay: Innovator in Cancer Treatment

Introduction

Scot Wayne McKay is a notable inventor based in Seattle, WA. He has made significant contributions to the field of medical treatments, particularly in cancer therapy. His innovative approach focuses on utilizing Intercellular Adhesion Molecule (ICAM)-modulating agents to treat cancer and lymphocyte-mediated diseases.

Latest Patents

Scot Wayne McKay holds a patent for "Methods of treatment using ICAM-modulating agents." This invention outlines methods for treating cancer and diseases mediated by lymphocytes, showcasing his commitment to advancing medical science.

Career Highlights

McKay is associated with Avm Biotechnology, LLC, where he applies his expertise in biotechnology to develop groundbreaking treatments. His work is pivotal in the ongoing fight against cancer, and he continues to explore new avenues for therapeutic interventions.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Scot Wayne McKay's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving healthcare outcomes. His work at Avm Biotechnology, LLC positions him as a key figure in the biotechnology industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…